Gadobutrol [Pre-filled syringe 1 mmol/mL (7.5 mL) Vial 1 mmol/mL (7.5 mL)] for diagnostic magnetic resonance imaging (MRI) in adults and children
Minor Inclusion | DrugsHTA Council Recommendation (as of 11 June 2026)
As a final recommendation, the HTA Council recommends the government financing of the following:
- Gadobutrol 1.0 mmol/mL solution for IV injection, 7.5 mL, in a clear colorless glass vial; and
- Gadobutrol 1.0 mmol/mL solution for IV injection, 7.5 mL in a type 1 colorless glass pre-filled syringe
for use in diagnostic magnetic resonance imaging (MRI) in adults and children.
Relevant Information
- Status: With Final HTA Council Recommendation and SOH Decision
- Topic Assignment: Internal Assessment
- Policy Question: Should gadobutrol [Pre-filled syringe 1 mmol/mL (7.5 mL) Vial 1 mmol/mL (7.5 mL)] for diagnostic magnetic resonance imaging (MRI) in adults and children be funded by the government?
- Secretary of Health Decision: Approved as of 18 July 2026
Evidence and Relevant Documents